PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jkneurosocJournal of Korean Neurosurgical SocietyJournalInstructions for AuthorsOn-line Submission
 
J Korean Neurosurg Soc. Dec 2008; 44(6): 375–381.
Published online Dec 31, 2008. doi:  10.3340/jkns.2008.44.6.375
PMCID: PMC2615141
Effect of Single Growth Factor and Growth Factor Combinations on Differentiation of Neural Stem Cells
Kyung-Chul Choi, M.D.,1 Do-Sung Yoo, M.D.,corresponding author1 Kyung-Sock Cho, M.D.,1 Pil-Woo Huh, M.D.,1 Dal-Soo Kim, M.D.,1 and Chun-Kun Park, M.D.2
1Department of Neurosurgery, Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, Korea.
2Department of Neurosurgery, Kangnam St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
corresponding authorCorresponding author.
Address for reprints: Do-Sung Yoo, M.D. Department of Neurosurgery, Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, 65-1 Geumo-dong, Uijeongbu 480-130, Korea. Tel: +82-31-820-3563, Fax: +82-31-847-3117, yooman/at/catholic.ac.kr
Received August 13, 2008; Accepted November 28, 2008.
Objective
The effects on neural proliferation and differentiation of neural stem cells (NSC) of basic fibroblast growth factor-2 (bFGF), insulin growth factor-I (IGF-I), brain-derived neurotrophic factor (BDNF), and nerve growth factor (NGF) were assessed. Also, following combinations of various factors were investigated : bFGF+IGF-I, bFGF+BDNF, bFGF+NGF, IGF-I+BDNF, IGF-I+NGF, and BDNF+NGF.
Methods
Isolated NSC of Fisher 344 rats were cultured with individual growth factors, combinations of factors, and no growth factor (control) for 14 days. A proportion of neurons was analyzed using β-tubulin III and NeuN as neural markers.
Results
Neural differentiations in the presence of individual growth factors for β-tubulin III-positive cells were : BDNF, 35.3%; IGF-I, 30.9%; bFGF, 18.1%; and NGF, 15.1%, and for NeuN-positive cells was : BDNF, 34.3%; bFGF, 32.2%; IGF-1, 26.6%; and NGF, 24.9%. However, neural differentiations in the absence of growth factor was only 2.6% for β-tubulin III and 3.1% for NeuN. For β-tubulin III-positive cells, neural differentiations were evident for the growth factor combinations as follows : bFGF+IGF-I, 73.1%; bFGF+NGF, 65.4%; bFGF+BDNF, 58.7%; BDNF+IGF-I, 52.2%; NGF+IGF-I, 40.6%; and BDNF+NGF, 40.0%. For NeuN-positive cells : bFGF+IGF-I, 81.9%; bFGF+NGF, 63.5%; bFGF+BDNF, 62.8%; NGF+IGF-I, 62.3%; BDNF+NGF, 56.3%; and BDNF+IGF-I, 46.0%. Significant differences in neural differentiation were evident for single growth factor and combination of growth factors respectively (p<0.05).
Conclusion
Combinations of growth factors have an additive effect on neural differentiation. The most prominent neural differentiation results from growth factor combinations involving bFGF and IGF-I. These findings suggest that the combination of a mitogenic action of bFGF and postmitotic differentiation action of IGF-I synergistically affects neural proliferation and NSC differentiation.
Keywords: Neuron, Single growth factor, Combination of growth factors, Synergistic effect
It had been known that neurons could not be regenerated in the adult central nervous system (CNS). Neuron was taken for granted to be in the G0 phase in its mitotic activity38). However, more recently, neural stem cells (NSC) were isolated from the walls of the ventricular zone of the CNS and the dentate gyrus of the hippocampus in adult mammals1,31). The NSC are defined as undifferentiated cells that have the ability of self-renewal and potentiality to differentiate into neurons, astrocytes, and oligodendrocytes in the CNS. The NSC give rise to immature neurons that migrate along the rostral migratory stream to the olfactory bulb, where they differentiate and integrate as interneurons in the rat11). NSC are potentially valuable as therapeutic tools for Parkinson's disease20), cerebral infarction8), spinal cord injury34), and many neurodegenerative diseases. Many attempts have been made to transplant NSC to remediate neurodegenerative diseases and CNS injuries in animal models; however, NSC which were transplanted differentiated into glial cells or remained undifferentiated7). Transplantation of only NSC fails to regenerate nervous systems9). Neuron cannot be regenerated despite the presence of NSC in the adult mammalian brain, because cell-extrinsic signals may inhibit differentiation of NSC to neurons35). Therefore, the micro-environment, including mitogens, hormones, genes, and stress is important in the proliferation, migration, survival, and differentiation aspects of neurogenesis3,13). However, the mechanism controlling NSC and progenitor cell proliferation remains only partially understood.
Presently, harvested NSC were cultured with single growth factors and combinations of growth factors for 2 weeks and the cell characteristics were evaluated with the specific neural markers. We investigated effects of neural differentiation in each growth factor and combination.
Cell suspension
Fisher 344 male or female rats weighing 170-190 g were deeply anesthetized with isofluran inhalation (5 Mac) for 10 min. The animals were decapitated and the whole brains were removed. The harvested brains were transported in a cold phosphate buffer solution (PBS). Two coronal cuts were made in the areas between the rhinal fissure and the hippocampus. The resulting tissue chunk was laid on its posterior surface, two parasagittal cuts were made just lateral to the lateral ventricles, and one horizontal cut was made at approximately the level of the corpus callosum35,36). Neurospheres were made by dissociating the central rectangular piece of tissue containing the lateral ventricles. The tissues were minced (1 mm3) with a knife and digested in a solution of papain (2.5 U/mL; Worthington, Freehold, NJ) dissolved in Hank's balanced salt solution (HBSS; Sigma-Aldrich, St. Louis, MO) for 30 min at 37[degree celsius]. The cells and tissue fragments were passed serially through ascending gauge needles (16 G, 18 G, 20 G, and 24 G), and washed three times with Dulbecco's Modified Eagle's Medium (DMEM; Sigma-Aldrich) containing 10% fetal bovine serum (FBS; Hyclone, Logan, UT) (DMEM-FBS). The whole digested tissue was suspended in DMEM-FBS and filtered through a sterile 50 µm nylon mesh. The Percoll solution was made by mixing nine parts of Percoll (Amersham Pharmacia Biotech, Uppsala, Sweden) to one part 10X PBS (Irvine Scientific, Santa Ana, CA). The cell suspension was then fractionated by high-speed centrifugation (20,000×g, 30 min, 18[degree celsius]) in the presence of blue and red marker beads. The cell fractions between the red and blue markers were harvested and washed free of Percoll by three or more rinses in DMEM-FBS21).
Cell culture
After isolation of NSC from the subventricular zone, the cells were cultured with single growth factors (bFGF, IGF-I, BDNF, and NGF), combinations of two factors (bFGF +IGF-I, bFGF+BDNF, bFGF+NGF, IGF-I+BDNF, IGF-I+NGF, and BDNF+NGF), or in the absence of growth factor (control) for 14 days. The cells fractionated through the Percoll gradients were washed free of Percoll and plated in flasks (Fisher Scientific, Pittsburgh, PA) or wells of multi-well dishes (Fisher Scientific) that had been coated with polyornithine/laminin (Sigma-Aldrich). For samples treated using a single growth factor, cells were allowed to attach over 24 h to the glass slides in DMEM/F-12 (1 : 1) containing 10% FBS (Gibco, Carlsbad, CA). The culture medium consisting of DMEM/F-12 (1 : 1) supplemented with either N2 supplement (Life Technologies, Gaithersburg, MD) and 20 ng/mL recombinant human FGF-2 (Roche Diagnostics, Indianapolis, IN), recombinant mouse IGF-I (R & D Systems, Minneapolis, MN), recombinant human BDNF (R & D Systems), or recombinant rat β-NGF (R & D Systems) was changed every 48 h for 14 days. For samples treated with a combination of two growth factors, the cells were allowed to attach as just described. The medium was supplemented with N2 supplement and 10 ng/mL bFGF+10 ng/mL IGF-I, 10 ng/mL bFGF+10 ng/mL BDNF, 10 ng/mL bFGF+10 ng/mL NGF, 10 ng/mL IGF-I+10 ng/mL BDNF, 10 ng/mL IGF-I+10 ng/mL NGF, or 10 ng/mL BDNF+10 ng/mL NGF. The medium was changed every 48 h for 14 days. A dish devoid of growth factor was used as a control.
Immunostaining
The culture media was removed after the cells have been cultured on polyornithine/laminin-coated glass chamber slides for 14 days. The cells were fixed with 4% paraformaldehyde in PBS for 10 min, rinsed three times (5 min each wash) with PBS and treated as follows. The cells were first pre-incubated with PBS containing 5% pre-immune donkey serum (PBS-DS) for 30 min and then incubated with primary antibodies for the cell surface markers; NeuN (Chemicon, Temecula, CA), β-tubulin-III (Covance, Berkeley, CA), O4 (Chemicon), and glial fibrillary acidic protein (GFAP; DAKO, Carpinteria, CA) in PBS-DS overnight at 4[degree celsius]. The cells were then washed three times, 10 min each, with PBS. Washed cells were then incubated for 2 h with secondary donkey anti-mouse IgG (Jackson Immuno Reseach, West Grove, PA; Cy-2, green color), and anti-rabbit IgG (Jackson Immuno Reseach; Cy-3, red color) diluted 1 : 200 in PBS-DS. The cells were then washed with PBS three times. The final wash contained 10 ng/mL 4,6-diamindino-2-phenylindole (DAPI; Molecular Probes, Eugene, OR) in PBS, which was used as a fluorescent counterstain for the cell nuclei. Samples were added to 100 mM Tris, pH 8.5, containing 25% glycerol, 10% polyvinyl alcohol (Air Products and Chemicals, Allen town, PA), 2.5% 1,4-diazobicyclo-[2.2.2]-octane (Sigma-Aldrich), a drop was placed on a slide, a coverslip was added, and counted as described below.
Cell counting and analysis
Immunofluorescent positive cells in each well were counted using an inverted fluorescent microscope. β-tubulin III and NeuN are neuron cell surface makers, O4 is a oligodendroglia marker, and GFAP is an astroglial cell marker. Neurons were defined as β-tubulin III- or NeuN-positive cells. The percentage of immunfluorescent neurons was analyzed as neural specific marker (NeuN or β-tubulin-III)-positive cells in comparison to all nucleated cells. All experiments were repeated 10 times and counted at least five times blindly in each well.
The statistical significance of differences between each mean of a single growth factor, combination of growth factors, and group were evaluated by one-way ANOVA with p<0.05 considered significant.
Neural differentiations were demonstrated by the expression of neural markers in neurons treated with single growth factors. For β-tubulin III-positive cells, the following percentages were observed : BDNF, 35.3%; IGF-I, 30.9%; bFGF, 18.1%; and NGF, 15.1%. For NeuN-positive cells the following percentages were observed : BDNF, 34.3%; bFGF, 32.2%; IGF-1, 26.6%; and NGF, 24.9% (Fig. 1, ,2).2). However, neurons were rarely evident when growth factor was absent (β-tubulin III, 2.6%; NeuN 3.1%). Significant differences were evident in neural differentiation with single growth factors (β-tubulin III, p=0.032; NeuN , p=0.039).
Fig. 1
Fig. 1
Immunocyotofluorescence for expressions of neuron specific markers (β-tubulin III, NeuN) in the neurogenic stimulation with brain-derived neurotrophic factor (A, E), basic fibroblast growth factor (B, F), insulin growth factor-I (C, G) and nerve (more ...)
Fig. 2
Fig. 2
Neuronal outgrowth and survival of neural stem cells in response to brain-derived neurotrophic factor, insulin growth factor-I, basic fibroblast growth factor, and nerve growth factor. Neurogenically stimulated cells were cultured for neural cell analysis (more ...)
Neural differentiations were also demonstrated when the growth factor combinations were used. For β-tubulin III-positive cells, the following results were obtainedbFGF+IGF-I, 73.1%; bFGF+NGF, 65.4%; bFGF+BDNF, 58.7%; BDNF+IGF-I, 52.2%; NGF+IGF-I, 40.6%; and BDNF+NGF, 40.0%. For NeuN-positive cells, the following results were obtained :bFGF+IGF-I, 81.9%; bFGF+NGF, 63.5%; bFGF+BDNF, 62.8%; NGF+IGF-I, 62.3%; BDNF+NGF, 56.3%; and BDNF+IGFI, 46.0% (Fig. 3, ,4).4). Significant differences in neural differentiation were evident (β-tubulin III, p=0.023; NeuN, p=0.018). All combinations of growth factors produced significantly more prominent neural proliferation and differentiation effect than any single growth factor.
Fig. 3
Fig. 3
Immunocyotofluorescence determined expression of neuron specific markers (β-tubulin III, NeuN) in the 14 day neurogenic stimulation by basic fibroblast growth factor (bFGF)+insulin growth factor-I (A, D), bFGF +brain-derived neurotrophic factor (more ...)
Fig. 4
Fig. 4
Neuronal outgrowth and survival of neural stem cells in response to basic fibroblast growth factor (bFGF) +insulin growth factor-I (IGF-I), bFGF +brain-derived neurotrophic factor (BDNF), bFGF +nerve growth factor (NGF), IGF-I +BDNF, IGF-I +NGF, and BDNF (more ...)
A partial proportion of neural-positive cells were labeled with GFAP or O4. The data of co-labeling neural-positive cell were summarized in Table 1. As aforementioned, GFAP and O4 are markers of glial cells. Both of them also attributed neural primitive cell/progenitor cell3,35). Although the cultured cells are not purified neural stem cells, it can conclude that a large part of these cultured cells are progenitor/stem cells21).
Table 1
Table 1
Co-labeling cells expressed with neural markers after 14 days in culture (%)
Improving the activity of NSC is important to increase the therapeutic potential of NSC to several diseases and experimental models. The primary concern of NSC transplant therapy ensures that many NSC as possible differentiate into functional neurons. The present study was prompted by the need to create appropriate micro-environments for neural differentiation in NSC transplantation. Here, we investigated the effects of growth factors on proliferation and differentiation of NSC.
Neurotrophins are a group of neurotrophic factors that play an essential role in neural development, differentiation, survival, regeneration, and function in both the central and peripheral nervous system. This neurotrophin family consists of NGF, BDNF, neurotrophin-3 (NT-3), neurotrophin-4/5 (NT-4/5), and neurotrophin-6 (NT-6)27). The effects of neurotrophins are mediated by an interaction with specific cell surface receptors19). NGF supports the survival and growth of peripheral sympathetic and primary sensory neurons, and also induces a variety of effects in CNS cells including activation of gene expression28), promotion of axons12), dendritic branching24), reduction of neuronal loss after injury, and the chemotrophic guidance of axons18,25). BDNF not only promotes cell differentiation, but offers strong neuroprotection that can be crucial for the survival of the stem cell in the CNS after implantation in vivo9). BDNF is extensively distributed in the developing and mature nervous system, and plays the most significant role in neural cell development, survival, and repair32). Kirschenbaum and Goldman reported that 35% of new neurons survived at 22 days in cultures exposed to BDNF in contrast to other neurotrophins (NGF, NT-3), which rarely affected neuronal viability22). There are differences of neural differentiation and proliferation in neurotrophins based on differences of distribution and affinity of receptor on the cell surface. Although BDNF supports the survival and proliferation of new neurons, this growth factor affects neither precursor mitosis nor initial commitment to neuronal lineage. BDNF does, however, affect the restricted differentiation, maturation, and survival of post-mitotic neuron2,15).
bFGF has a much broader range of effects and supports the survival of a variety of neurons from different regions of the brain. It is well-known that bFGF is a necessary factor for maintaining proliferative multipotent precursors in vitro16,35). bFGF is a mitogen that induce multipotent stem cells to proliferate and stimulate committed neuronal precursors to produce neurons or astrocytes. NSC can differentiate into neurons or glial cells in the presence of bFGF in a dose-dependent manner. For example, neurons were differentiated at low concentration (0.1 ng/mL) of bFGF in rat embryonic NSC, while both neurons and astrocytes differentiate at high concentration (10 ng/mL)13). Infused bFGF also acts as a mitogen in the rat ventricle26).
IGF-I and IGF-I receptors are present throughout the CNS during embryogenesis, and their mRNAs are discretely localized in certain neuronal populations4,6). The presence of IGF-I and receptor suggests that this factor may play important a role in neurogenesis. Neurons are generated in a dose-dependent manner upon culture of NSC by IGF-I2). However, IGF-I has no mitogenic action in contrast with bFGF, and restrictively affects post-mitogenic differentiation2,3). In particular, IGF-I promotes the differentiation of the same neuronal precursors as does BDNF, with both utilizing tyrosin kinase receptors23,29), activating p21ras as part of their signal transduction33,37), and supporting the survival of mesencephalic dopamine and motor neurons5,30). Differentially, BDNF presents neurons containing GABA while IGF-I presents neurons containing amino-acid transmitters2,14).
In our study, each growth factor that was examined affected neural differentiation in NSC cultures over 14 days. Variations in differentiation were apparent depending on the growth factor used. Neural presentation was most prominent using BDNF. However, use of a single growth factor consistently produced a low rate of neural differentiation (15%-35%).
Presently, we observed that combinations of growth factors consistently promoted more neural differentiation than any single growth factor. The combinations of growth factors had an additive effect on NSC differentiation. In particular, the combination of bFGF and IGF-I synergistically affected neural proliferation and differentiation of NSC, producing the most prominent neural differentiation noted in this study. Arsenijevic et al. suggested that IGF-I plays an important role with bFGF in neurogenesis based on the fact that IGF-I receptors are expressed in germinal regions that colocalize with FGF-receptor3). Moreover, Drago et al. reported that IGF-I acted as a survival factor for an FGF-2 responsive progenitor cell that give rise to neurons10). We considered that the combination of a potent mitogenic action of bFGF and post-mitotic differentiation of IGF-I has a synergistic effect on neural proliferation and differentiation of NSC.
Subsequently, bFGF+NGF and bFGF+BDNF displayed additive effects and quite prominent effects on neural proliferation and differentiation. We found that more neurons were differentiated and proliferated in the presence of combinations of factors, which regulated mitosis (bFGF) and post-mitotic processes (IGF-I, NGF, BDNF; Fig. 5). The result of the present study also demonstrated that combination of BDNF and NGF displayed an additive effect and presented more neuron on neural differentiation. Hanson et al. reported that additive effects were found concerning survival in short-term culture of spinal motor neuron when multiple neurotrophic factors were combined17).
Fig. 5
Fig. 5
Schematic pathway for neurogenesis by neural stem cells in vitro. Basic fibroblast growth factor induce neural stem cells to proliferate. Insulin growth factor-I, brain-derived neurotrophic factor, and nerve growth factor act to induce the differentiation (more ...)
CONCLUSION
Combinations of growth factors produce a prominent effect on neural proliferation and differentiation than any single factor. Presently, neural differentiation was most prominently presented in the presence of bFGF+IGF-I. These findings suggest that the combination of the mitogenic action of bFGF and the influence on post-mitotic differentiation of IGF-I synergistically affects neural proliferation and differentiation of NSC.
Acknowledgements
The authors wish to acknowledge the financial support of the Catholic Institute of Cell therapy Basic Science Programs Foundation made in the program year of 2007.
1. Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol. 1965;124:319–335. [PubMed]
2. Arsenijevic Y, Weiss S. Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors : distinct actions from those of brain-derived neurotrophic factor. J Neurosci. 1998;18:2118–2128. [PubMed]
3. Arsennijevic Y, Weiss S, Schneider B, Aebischer P. Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2. J Neurosci. 2001;21:7194–7202. [PubMed]
4. Bartlett WP, Li XS, Williams M, Benkovic S. Localization of insulin-like growth factor-1 mRNA in murine central nervous system during postnatal development. Dev Biol. 1991;147:239–250. [PubMed]
5. Beck KD, Knüsel B, Hefti F. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience. 1993;52:855–866. [PubMed]
6. Bondy CA, Werner H, Roberts CT, Jr, LeRoith D. Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis : comparison with IGF-II gene expression. Mol Endocrinol. 1990;4:1386–1398. [PubMed]
7. Cao QL, Zhang YP, Howard RM, Walters WM, Tsoulfas P, Whittemore SR. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol. 2001;167:48–58. [PubMed]
8. Chen J, Li Y, Chopp M. Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology. 2000;39:711–716. [PubMed]
9. Chen X, Li Y, Wang L, Katakowski M, Zhang L, Chen J, et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology. 2002;22:275–279. [PubMed]
10. Drago J, Murphy M, Carroll SM, Harvey RP, Bartlett PF. Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc Natl Acad Sci U S A. 1991;88:2199–2203. [PubMed]
11. Gage FH. Mammalian neural stem cells. Science. 2000;287:1433–1438. [PubMed]
12. Gage FH, Armstrong DM, Williams LR, Varon S. Morphological response of axotomized septal neurons to nerve growth factor. J Comp Neurol. 1988;269:147–155. [PubMed]
13. Gage FH, Coates PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, et al. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A. 1995;92:11879–11883. [PubMed]
14. Gao WQ, Zheng JL, Karihaloo M. Neurotrophin-4/5 (NT-4/5) and brain-derived neurotrophic factor (BDNF) act at later stages of cerebellar granule cell differentiation. J Neurosci. 1995;15:2656–2667. [PubMed]
15. Ghosh A, Carnahan J, Greenberg ME. Requirement for BDNF in activity-dependent survival of cortical neurons. Science. 1994;263:1618–1623. [PubMed]
16. Gritti A, Parati EA, Cova L, Frolichsthal P, Galli R, Wanke E, et al. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci. 1996;16:1091–1100. [PubMed]
17. Hanson MG, Jr, Shen S, Wiemelt AP, McMorris FA, Barres BA. Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J Neurosci. 1998;18:7361–7371. [PubMed]
18. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci. 1986;6:2155–2162. [PubMed]
19. Hohn A, Leibrock J, Bailey K, Barde YA. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature. 1990;344:339–341. [PubMed]
20. Kim JH, Auerbach JM, Rodríguez-Gómez JA, Velasco I, Gavin D, Lumelsky N, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature. 2002;418:50–56. [PubMed]
21. Kim JT, Yoo DS, Woo JH, Huh PH, Cho KS, Kim DS. The cell survival and differentiation after transplantation, which harvest from adult rat brain by high-speed centrifugation method. J Korean Neurosurg Soc. 2005;38:121–125.
22. Kirschenbaum B, Goldman SA. Brain-derived neurotrophic factor promotes the survival of neurons arising from the adult rat forebrain subependymal zone. Proc Natl Acad Sci U S A. 1995;92:210–214. [PubMed]
23. Klein R, Nanduri V, Jing SA, Lamballe F, Tapley P, Bryant S, et al. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 1991;66:395–403. [PMC free article] [PubMed]
24. Kolb B, Cote S, Ribeiro-da-Silva A, Cuello AC. Nerve growth factor treatment prevents dendritic atrophy and promotes recovery of function after cortical injury. Neuroscience. 1997;76:1139–1151. [PubMed]
25. Kromer LF. Nerve growth factor treatment after brain injury prevents neuronal death. Science. 1987;235:214–216. [PubMed]
26. Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci. 1997;17:5820–5829. [PubMed]
27. Kwon HJ, Lee KY, Park IK, Park MS, Lee MY, Kim MK. Expression of tyrosine kinase A in the cerebral cortex of postnatal developing rat. J Vet Sci. 2005;6:185–189. [PubMed]
28. Leonard DG, Ziff EB, Greene LA. Identification and characterization of mRNAs regulated by nerve growth factor in PC12 cells. Mol Cell Biol. 1987;7:3156–3167. [PMC free article] [PubMed]
29. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT., Jr Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 1995;16:143–163. [PubMed]
30. Li L, Oppenheim RW, Lei M, Houenou LJ. Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. J Neurobiol. 1994;25:759–766. [PubMed]
31. Lois C, Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A. 1993;90:2074–2077. [PubMed]
32. Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol. 2001;63:71–124. [PubMed]
33. Ng NF, Shooter EM. Activation of p21ras by nerve growth factor in embryonic sensory neurons and PC12 cells. J Biol Chem. 1993;268:25329–25333. [PubMed]
34. Onifer SM, Cannon AB, Whittemore SR. Altered differentiation of CNS neural progenitor cells after transplantation into the injured adult rat spinal cord. Cell Transplant. 1997;6:327–338. [PubMed]
35. Palmer TD, Markakis EA, Willhoite AR, Safar F, Gage FH. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci. 1999;19:8487–8497. [PubMed]
36. Palmer TD, Takahashi J, Gage FH. The adult rat hippocampus contains primordial neural stem cells. Mol Cell Neurosci. 1997;8:389–404. [PubMed]
37. Robinson LJ, Leitner W, Draznin B, Heidenreich KA. Evidence that p21ras mediates the neurotrophic effects of insulin and insulin-like growth factor I in chick forebrain neurons. Endocrinology. 1994;135:2568–2573. [PubMed]
38. Sugita N. Comparative studies on the growth of the cerebral cortex. J Comp Neurol. 1918:61–117.
Articles from Journal of Korean Neurosurgical Society are provided here courtesy of
The Korean Neurosurgical Society